1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America In-Vitro Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America In-Vitro Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America In-Vitro Diagnostics Market Regional Analysis
6.2 North America In-Vitro Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 North America In-Vitro Diagnostics Market Forecast Analysis
7. North America In-Vitro Diagnostics Market Analysis – by Product & Services
7.1 Reagents & Kits
- 7.1.1 Overview
- 7.1.2 Reagents & Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Software & Services
- 7.3.1 Overview
- 7.3.2 Software & Services: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America In-Vitro Diagnostics Market Analysis – by Technology
8.1 Immunoassay/Immunochemistry
- 8.1.1 Overview
- 8.1.2 Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Clinical Chemistry
- 8.2.1 Overview
- 8.2.2 Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Molecular Diagnostics
- 8.3.1 Overview
- 8.3.2 Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Microbiology
- 8.4.1 Overview
- 8.4.2 Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Blood Glucose Self-Monitoring
- 8.5.1 Overview
- 8.5.2 Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.6 Coagulation & Hemostasis
- 8.6.1 Overview
- 8.6.2 Coagulation & Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.7 Hematology
- 8.7.1 Overview
- 8.7.2 Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.8 Urinalysis
- 8.8.1 Overview
- 8.8.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America In-Vitro Diagnostics Market Analysis – by Application
9.1 Infectious Diseases
- 9.1.1 Overview
- 9.1.2 Infectious Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Oncology
- 9.3.1 Overview
- 9.3.2 Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Nephrology
- 9.6.1 Overview
- 9.6.2 Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America In-Vitro Diagnostics Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Laboratories
- 10.2.1 Overview
- 10.2.2 Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Homecare
- 10.3.1 Overview
- 10.3.2 Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. North America In-Vitro Diagnostics Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America In-Vitro Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 North America In-Vitro Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 US: North America In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.1.2 US: North America In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 US: North America In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.1.4 US: North America In-Vitro Diagnostics Market Breakdown, by End User
- 11.2.1.2 Canada:
North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Canada: North America In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.2.2 Canada: North America In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Canada: North America In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.2.4 Canada: North America In-Vitro Diagnostics Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Product & Services
- 11.2.1.3.2 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Application
- 11.2.1.3.4 Mexico : North America In-Vitro Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Becton Dickinson and Co
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 bioMerieux SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bio-Rad Laboratories Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Danaher Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Qiagen NV
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Siemens AG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Sysmex Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Thermo Fisher Scientific Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America In-Vitro Diagnostics Market
